12 Amendments of Alexandr VONDRA related to 2024/2030(DEC)
Amendment 3 #
Draft opinion
Paragraph 2
Paragraph 2
2. Considers that regular visits to the Agencies are a key aspect of the scrutiny exercised by the European Parliament over them; notes toin this regard the success of the ENVI delegation to the EMA in February 2023 and to the ECHA in April 2023;, which facilitated constructive dialogue, enhanced transparency, and strengthened the Parliament's oversight role.
Amendment 6 #
Draft opinion
Paragraph 3
Paragraph 3
3. Expresses its satisfaction that the European Court of Auditors (ECA) has declared the transactions of the Agencieconfirmed the legality and regularity, in all material respects, of the transactions underlying the Agencies' annual accounts for the financial year 2023 to be legal and regular in all material respects, and that, as well as the fair representation of their financial position, ats of 31 December 2023, is fairly represented in all material respects;
Amendment 10 #
Draft opinion
Paragraph 5
Paragraph 5
5. Welcomes the fact that the Agencies tookhave implemented effective corrective actions followingin response to most of the 2022 observations from the ECA; takes note of the 2023 observations forregarding the Agencies, in particular observationsly those related to ex-ante checks, and calls on them to ensure an effective follow-up.emphasises the importance of addressing these issues promptly and thoroughly; calls on the Agencies to maintain their commitment to transparency and accountability through an effective and timely follow-up process;
Amendment 15 #
Draft opinion
Paragraph 2
Paragraph 2
2. Notes that the ECDC mandate was extended following the adoption of Regulation (EU) 2022/23701 which entered into force on 13 December 2022 in order to strengthen the Union's health security framework in the fields of epidemiological surveillance; welcomes the fact that the ECDC began to implement its new mandate by reviewing the modalities of collaboration with its main partners and stakeholders, as well as the structure and content of its Strategy 2021-2027; , while emphasising the importance of ensuring accountability and transparency throughout this process; _________________ 1 Regulation (EU) 2022/2370 of the European Parliament and of the Council of 23 November 2022 amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control (OJ L 314, 6.12.2022, p. 1–25 ELI: http://data.europa.eu/eli/reg/2022/2370/oj)
Amendment 17 #
Draft opinion
Paragraph 3
Paragraph 3
3. Welcomes the continued development of the One Health Framework and the creation of the One Health Task Force to strengthen collaboration with EMA, EFSA, EEA and ECHA; highlights the importance of ensuring good and fair cooperation between the Agencies, while cautioning against inefficiencies, duplication of efforts, and overlapping mandates;
Amendment 28 #
Draft opinion
Paragraph 1
Paragraph 1
1. Acknowledges that the ECHA is key in implementing a growing number of Union legislation that regulates chemicals for the benefit of public health and the environment, as well as for innovation and competitiveness; recognises that the ECHA collects, evaluates, and disseminates a vast amount ofextensive information on chemicals, helpassists companies in complying with legislation, and promotes the safe use of chemicals;
Amendment 34 #
Draft opinion
Paragraph 3
Paragraph 3
3. Recalls the necessity of ensuring adequate staffing reflecting the needs of the European Green Deal and the Union Chemical Strategy for Sustainability, Circular Economy Action Plan and, in particular, the zero pollution target, and the associated increase in tasks;
Amendment 37 #
Draft opinion
Paragraph 5 a (new)
Paragraph 5 a (new)
5 a. Notes that, despite falling short of fulfilling key indicators for the identification and prioritisation of hazardous substances, the Agency's 2023 annual report highlights that ECHA screened 61 groups covering approximately 1,380 substances, surpassing its initial target, and identified 320 substances for potential risk management, 280 requiring further data, and 540 requiring no further action; furthermore, acknowledges that by the end of 2023, ECHA had assessed 92% of substances registered above 100 tonnes, leaving fewer than 400 high-tonnage substances still to be evaluated;
Amendment 51 #
Draft opinion
Paragraph 2
Paragraph 2
2. Acknowledges the adaptability of the EEA, which, in addition to its planned publications for 2023, releasproduced additional works on topics ranging from extreme weather to human health, such asincluding The iImportance on rf Restoring nNature in Europe, demonstrating its capacity to inform and fuel currentcontribute to policy debates arising from evolving circumstances;
Amendment 61 #
Draft opinion
Paragraph 6
Paragraph 6
6. Takes note with concern that despite the multi-year nature of the EEA’s tasks, an imbalance exists concerning the numbers of permanent versus contractual posts, as well as operational staff versus support staff, leading to a constant need for reskilling as well as an overload of administrative work for scientists; considers that taking into account the substantial increase of workload, and in order to properly perform the tasks on the Union’s goals for, inter alia, climate neutrality, circular economy and nature rehighlights the importance of aligning staff resources with the EEA’s long-term responsibilities and growing demands, potentially requiring a gradual and storation, the EEA’s staff number should continue to substantially grow in the years to coegic adjustment in staff numbers over time.;
Amendment 67 #
Draft opinion
Paragraph 2
Paragraph 2
2. Welcomes the involvement of the EFSA in ENVI’s work and more generally the engagement of EFSA with initiatives related to the Farm to Fork and the Union Chemical strategies, with a particular emphasis on pesticides, nutrition, animal welfare, and chemical risk assessment; stresses the need for these efforts to remain firmly grounded in robust, evidence-based policy-making, including the establishingment of an Union chemicals data platform, to ensure that decisions are informed by the best available scientific data and promote effective and balanced regulatory outcomes;
Amendment 103 #
Draft opinion
Paragraph 7
Paragraph 7
7. Notes that thewith concern the increasingly challenging situation regarding the EMA’s former premises in London became increasingly challenging in 2023, with a need for the EMA to dedicate, which in 2023 required significant levels of resources to managinge commercial real estate in a third country, endang; this burden risks diverting its core activities; calls onattention and resources from the EMA’s core public health mission; urges the Commission to prioritise secureing a long-term political and financial resolution tof this issue and to allow, including exploring options such as renegotiating terms or repurposing the premises, to prevent unnecessary expenditure and enable the EMA to fully focus its efforts on its public health mission.